account_id none on file
legal_name BGM Group Ltd.
ticker BGM
cik 1779578
domain bgmgroupltd.com
linkedin_company_url https://www.linkedin.com/company/bgm-holding/
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 2 executives 0 family 0
why_nownone on file
callsnone on file
filings
Gross margin of our oxytetracycline and licorice products increased from 6.0% to 16.6% primarily due to 1) the newly developed licorice extract products have low costs, and the ratio of dry and wet licorice is constantly adjusted to reduce costs and increase gross margin; 2) as described before, the price of licorice products has increased, resulting in an increase in gross profit
filing / Jul 21, 2026 / receipt
Yaxuan Zhai has served as our chief financial officer since May 2024 and had served as the finance manager at the Company from October 2023 to May 2024.
filing / Jul 21, 2026 / receipt
executivesnone on file
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
slug bgm-group-ltd
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$